(Q46073594)

English

Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

author name string

Debra W Kemp

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

Kira R Brice

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

language of work or name

0 references

publication date

1 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

29

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

468-472

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Haemoglobin A1 and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and th

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Standards of medical care in diabetes--2007.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Anemia and the role of erythropoietin in diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Translating the A1C assay into estimated average glucose values

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

A method for estimating the probability of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.4.468

21 January 2018

Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1681/ASN.2006070772

Identifiers

10.1592/PHCO.29.4.468

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19323622

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46073594&oldid=2090673520"